These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24531547)

  • 1. Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.
    Demeule M; Beaudet N; Régina A; Besserer-Offroy É; Murza A; Tétreault P; Belleville K; Ché C; Larocque A; Thiot C; Béliveau R; Longpré JM; Marsault É; Leduc R; Lachowicz JE; Gonias SL; Castaigne JP; Sarret P
    J Clin Invest; 2014 Mar; 124(3):1199-213. PubMed ID: 24531547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a Noninvasive Brain-Penetrating Peptide-Drug Conjugate Strategy to Improve the Delivery of Opioid Pain Relief Medications to the Brain.
    Eiselt É; Otis V; Belleville K; Yang G; Larocque A; Régina A; Demeule M; Sarret P; Gendron L
    J Pharmacol Exp Ther; 2020 Jul; 374(1):52-61. PubMed ID: 32327529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia.
    Vivancos M; Fanelli R; Besserer-Offroy É; Beaulieu S; Chartier M; Resua-Rojas M; Mona CE; Previti S; Rémond E; Longpré JM; Cavelier F; Sarret P
    Behav Brain Res; 2021 May; 405():113189. PubMed ID: 33607165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity.
    Roussy G; Dansereau MA; Baudisson S; Ezzoubaa F; Belleville K; Beaudet N; Martinez J; Richelson E; Sarret P
    Mol Pain; 2009 Jul; 5():38. PubMed ID: 19580660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain.
    Guillemette A; Dansereau MA; Beaudet N; Richelson E; Sarret P
    Eur J Pain; 2012 Apr; 16(4):473-84. PubMed ID: 22396077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratio.
    Eiselt E; Côté J; Longpré JM; Blais V; Sarret P; Gendron L
    Eur J Pharmacol; 2019 Apr; 848():80-87. PubMed ID: 30707956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANG4043, a novel brain-penetrant peptide-mAb conjugate, is efficacious against HER2-positive intracranial tumors in mice.
    Regina A; Demeule M; Tripathy S; Lord-Dufour S; Currie JC; Iddir M; Annabi B; Castaigne JP; Lachowicz JE
    Mol Cancer Ther; 2015 Jan; 14(1):129-40. PubMed ID: 25492620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic.
    Chartier M; Desgagné M; Sousbie M; Côté J; Longpré JM; Marsault E; Sarret P
    J Med Chem; 2021 Feb; 64(4):2110-2124. PubMed ID: 33538583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog.
    Tétreault P; Besserer-Offroy É; Brouillette RL; René A; Murza A; Fanelli R; Kirby K; Parent AJ; Dubuc I; Beaudet N; Côté J; Longpré JM; Martinez J; Cavelier F; Sarret P
    Eur J Pharmacol; 2020 Sep; 882():173174. PubMed ID: 32534076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors.
    Sarret P; Esdaile MJ; Perron A; Martinez J; Stroh T; Beaudet A
    J Neurosci; 2005 Sep; 25(36):8188-96. PubMed ID: 16148226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia.
    Eiselt E; Gonzalez S; Martin C; Chartier M; Betti C; Longpré JM; Cavelier F; Tourwé D; Gendron L; Ballet S; Sarret P
    ACS Chem Neurosci; 2019 Nov; 10(11):4535-4544. PubMed ID: 31589400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model.
    Roussy G; Dansereau MA; Doré-Savard L; Belleville K; Beaudet N; Richelson E; Sarret P
    J Neurochem; 2008 May; 105(4):1100-14. PubMed ID: 18182046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analog.
    Chartier M; Desgagné M; Sousbie M; Rumsby C; Chevillard L; Théroux L; Haroune L; Côté J; Longpré JM; Boudreault PL; Marsault É; Sarret P
    Biomed Pharmacother; 2021 Sep; 141():111861. PubMed ID: 34229249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
    Smith KE; Boules M; Williams K; Richelson E
    Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced inhibitory synaptic transmission in the spinal dorsal horn mediates antinociceptive effects of TC-2559.
    Cheng LZ; Han L; Fan J; Huang LT; Peng LC; Wang Y
    Mol Pain; 2011 Aug; 7():56. PubMed ID: 21816108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive effects of potent, selective and brain penetrant muscarinic M
    Grauer SM; Sanoja R; Poulin D; Rashid H; Jochnowitz N; Calhoun M; Zwilling D; Varty GB; Rosahl TW; Meziane H; Mittlelhaeuser C; Mazzola R; Morrow J; Smith SM; Henze D; Marcus J
    Brain Res; 2020 Jun; 1737():146814. PubMed ID: 32234514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT69L, a novel analgesic, shows synergy with morphine.
    Boules M; Shaw A; Liang Y; Barbut D; Richelson E
    Brain Res; 2009 Oct; 1294():22-8. PubMed ID: 19651107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analgesic synergy of neurotensin receptor subtype 2 agonist NT79 and morphine.
    Boules M; Johnston H; Tozy J; Smith K; Li Z; Richelson E
    Behav Pharmacol; 2011 Sep; 22(5-6):573-81. PubMed ID: 21691202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.
    Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J
    J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal NTS2 receptor activation reverses signs of neuropathic pain.
    Tétreault P; Beaudet N; Perron A; Belleville K; René A; Cavelier F; Martinez J; Stroh T; Jacobi AM; Rose SD; Behlke MA; Sarret P
    FASEB J; 2013 Sep; 27(9):3741-52. PubMed ID: 23756650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.